ABVC Annual Accounts Payable
N/A
31 December 2023
Summary:
ABVC annual accounts payable is not available.ABVC Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABVC Quarterly Accounts Payable
N/A
30 September 2024
Summary:
ABVC quarterly accounts payable is not available.ABVC Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABVC Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
ABVC Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
ABVC BioPharma Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $2100.00(-87.3%) |
| Sept 2021 | - | $16.50 K(+230.0%) |
| June 2021 | - | $5000.00(-51.5%) |
| Mar 2021 | - | $10.30 K(-55.2%) |
| Dec 2020 | $23.00 K(-4.2%) | $23.00 K(-0.4%) |
| Sept 2020 | - | $23.10 K(+196.2%) |
| June 2020 | - | $7800.00(-61.8%) |
| Mar 2020 | - | $20.40 K(-15.0%) |
| Dec 2019 | $24.00 K(+30.4%) | $24.00 K(+79.1%) |
| Sept 2019 | - | $13.40 K(-32.0%) |
| June 2019 | - | $19.70 K(+26.3%) |
| Mar 2019 | - | $15.60 K(>+9900.0%) |
| June 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | - | $0.00(-100.0%) |
| Sept 2016 | $18.40 K(>+9900.0%) | $18.40 K(+61.4%) |
| June 2016 | - | $11.40 K(>+9900.0%) |
| Sept 2015 | $0.00(-100.0%) | $0.00(-100.0%) |
| Mar 2013 | - | $165.00 K(0.0%) |
| Dec 2012 | - | $165.00 K(+104.2%) |
| Sept 2012 | $80.80 K(-67.1%) | $80.80 K(+225.8%) |
| June 2012 | - | $24.80 K(+34.1%) |
| Mar 2012 | - | $18.50 K(-53.8%) |
| Dec 2011 | - | $40.00 K(-83.7%) |
| Sept 2011 | $245.90 K(-80.0%) | $245.90 K(+1517.8%) |
| June 2011 | - | $15.20 K(+123.5%) |
| Mar 2011 | - | $6800.00(-99.5%) |
| Dec 2010 | - | $1.24 M(+0.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2010 | $1.23 M(-3.1%) | $1.23 M(+5.1%) |
| June 2010 | - | $1.17 M(-12.9%) |
| Mar 2010 | - | $1.35 M(+7.1%) |
| Dec 2009 | - | $1.26 M(-1.2%) |
| Sept 2009 | $1.27 M(-6.4%) | $1.27 M(-9.1%) |
| June 2009 | - | $1.40 M(+0.5%) |
| Mar 2009 | - | $1.39 M(-2.6%) |
| Dec 2008 | - | $1.43 M(+5.1%) |
| Sept 2008 | $1.36 M(+216.3%) | $1.36 M(+22.0%) |
| June 2008 | - | $1.11 M(+48.7%) |
| Mar 2008 | - | $749.10 K(+22.0%) |
| Dec 2007 | - | $614.00 K(>+9900.0%) |
| Sept 2007 | $429.80 K(>+9900.0%) | - |
| June 2007 | - | $2600.00(-62.9%) |
| Mar 2007 | - | $7000.00(+125.8%) |
| Dec 2006 | $3100.00(+14.8%) | $3100.00(-50.0%) |
| Sept 2006 | - | $6200.00(+10.7%) |
| June 2006 | - | $5600.00(-21.1%) |
| Mar 2006 | - | $7100.00(+163.0%) |
| Dec 2005 | $2700.00(-10.0%) | $2700.00(+285.7%) |
| Sept 2005 | - | $700.00(-85.4%) |
| June 2005 | - | $4800.00(-29.4%) |
| Mar 2005 | - | $6800.00(+126.7%) |
| Dec 2004 | $3000.00(-71.2%) | $3000.00(-47.4%) |
| Sept 2004 | - | $5700.00(-6.6%) |
| June 2004 | - | $6100.00(+134.6%) |
| Mar 2004 | - | $2600.00 |
| Dec 2003 | $10.40 K | - |
FAQ
- What is the all time high annual accounts payable for ABVC BioPharma?
- What is the all time high quarterly accounts payable for ABVC BioPharma?
What is the all time high annual accounts payable for ABVC BioPharma?
ABVC BioPharma all-time high annual accounts payable is $1.36 M
What is the all time high quarterly accounts payable for ABVC BioPharma?
ABVC BioPharma all-time high quarterly accounts payable is $1.43 M